Table 1
Â
|
No (N=2041) |
Yes (N=837) |
P-value |
| Cohort |
|
|
|
| Original |
1431 (70.1%) |
506 (60.5%) |
<0.001 |
| Expansion |
339 (16.6%) |
192 (22.9%) |
|
| Replacement |
271 (13.3%) |
139 (16.6%) |
|
| Gender |
|
|
|
| Female |
1139 (55.8%) |
481 (57.5%) |
0.439 |
| Male |
902 (44.2%) |
356 (42.5%) |
|
| Age at Death |
|
|
|
| Mean (SD) |
86.6 (7.18) |
89.2 (6.65) |
<0.001 |
| Median [Min, Max] |
87.2 [66.4, 108] |
89.7 [68.9, 106] |
|
| Year of Death |
|
|
|
| Mean (SD) |
2010 (6.80) |
2010 (6.00) |
<0.001 |
| Median [Min, Max] |
2010 [1990, 2020] |
2010 [2000, 2020] |
|
| race_cat_simp_adjusted |
|
|
|
| Non-White |
220 (10.8%) |
49 (5.9%) |
<0.001 |
| White |
1821 (89.2%) |
788 (94.1%) |
|
| APOE_adjusted_no |
|
|
|
| - APOE e4 |
1586 (77.7%) |
612 (73.1%) |
0.01 |
| + APOE e4 |
455 (22.3%) |
225 (26.9%) |
|
| Ever Smoker |
|
|
|
| No |
929 (45.5%) |
377 (45.0%) |
0.848 |
| Yes |
1112 (54.5%) |
460 (55.0%) |
|
| alcohol_cat_adjusted |
|
|
|
| Never |
432 (21.2%) |
155 (18.5%) |
0.025 |
| Former |
581 (28.5%) |
214 (25.6%) |
|
| Current |
1028 (50.4%) |
468 (55.9%) |
|
| exercise_cat_adjusted |
|
|
|
| No |
679 (33.3%) |
249 (29.7%) |
0.073 |
| Yes |
1362 (66.7%) |
588 (70.3%) |
|
| Education |
|
|
|
| Less than High School |
271 (13.3%) |
65 (7.8%) |
<0.001 |
| GED |
49 (2.4%) |
12 (1.4%) |
|
| High School |
915 (44.8%) |
341 (40.7%) |
|
| Bachelor's |
391 (19.2%) |
198 (23.7%) |
|
| Master's |
187 (9.2%) |
111 (13.3%) |
|
| Doctorate |
70 (3.4%) |
46 (5.5%) |
|
| Other |
158 (7.7%) |
64 (7.6%) |
|
| education_cat_adjusted |
|
|
|
| < 13 |
815 (39.9%) |
243 (29.0%) |
<0.001 |
| 13-16 |
851 (41.7%) |
364 (43.5%) |
|
| 17+ |
375 (18.4%) |
230 (27.5%) |
|
| nses_z_cx_adjusted |
|
|
|
| Mean (SD) |
-0.656 (0.715) |
-0.692 (0.709) |
0.217 |
| Median [Min, Max] |
-0.775 [-2.66, 2.64] |
-0.798 [-2.66, 2.47] |
|
| PM2.5 Exposure from Death (10 year) |
|
|
|
| Mean (SD) |
8.81 (2.23) |
7.97 (1.66) |
<0.001 |
| Median [Min, Max] |
8.47 [3.77, 17.1] |
7.72 [4.03, 14.6] |
|
| NO2 Exposure from Death (10 year) |
|
|
|
| Mean (SD) |
13.9 (3.80) |
13.4 (3.51) |
<0.001 |
| Median [Min, Max] |
13.4 [4.82, 35.0] |
12.7 [4.88, 30.7] |
|
| Heart_Dis |
|
|
|
| No |
1148 (56.2%) |
570 (68.1%) |
0.007 |
| Yes |
646 (31.7%) |
250 (29.9%) |
|
| Missing |
247 (12.1%) |
17 (2.0%) |
|
| Hypertension |
|
|
|
| No |
599 (29.3%) |
324 (38.7%) |
0.003 |
| Yes |
1195 (58.5%) |
496 (59.3%) |
|
| Missing |
247 (12.1%) |
17 (2.0%) |
|
| Diabetes |
|
|
|
| No |
1457 (71.4%) |
690 (82.4%) |
0.078 |
| Yes |
337 (16.5%) |
130 (15.5%) |
|
| Missing |
247 (12.1%) |
17 (2.0%) |
|
| bmi_adjusted |
|
|
|
| Mean (SD) |
27.4 (4.85) |
26.9 (4.74) |
0.007 |
| Median [Min, Max] |
27.0 [15.7, 50.3] |
26.3 [15.9, 48.9] |
|
| Dementia Status |
|
|
|
| No Dementia |
1363 (66.8%) |
456 (54.5%) |
<0.001 |
| Dementia |
678 (33.2%) |
381 (45.5%) |
|
| Arrhythmia |
|
|
|
| No |
1339 (65.6%) |
549 (65.6%) |
1 |
| Yes |
702 (34.4%) |
288 (34.4%) |
|
| Had Autopsy |
|
|
|
| No |
2041 (100%) |
0 (0%) |
<0.001 |
| Yes |
0 (0%) |
837 (100%) |
|
| CV_DIS_adj |
|
|
|
| 1 |
1804 (88.4%) |
741 (88.5%) |
0.965 |
| 2 |
237 (11.6%) |
96 (11.5%) |
|
| Marital Status |
|
|
|
| Married |
1051 (51.5%) |
454 (54.2%) |
0.194 |
| Not Married |
990 (48.5%) |
383 (45.8%) |
|
| Hipposcampal Sclerosis |
|
|
|
| 0 |
0 (0%) |
692 (82.7%) |
NA |
| 1 |
0 (0%) |
123 (14.7%) |
|
| Missing |
2041 (100%) |
22 (2.6%) |
|
| as.factor(Hippocampal_Sclerosis) |
|
|
|
| Bilateral |
0 (0%) |
7 (0.8%) |
NA |
| Missing/Unknown |
0 (0%) |
16 (1.9%) |
|
| None |
0 (0%) |
692 (82.7%) |
|
| Present, but laterality not assessed |
0 (0%) |
89 (10.6%) |
|
| Unilateral |
0 (0%) |
11 (1.3%) |
|
| Missing |
2041 (100%) |
22 (2.6%) |
|
| Lewy Body Disease |
|
|
|
| 0 |
0 (0%) |
657 (78.5%) |
NA |
| 1 |
0 (0%) |
180 (21.5%) |
|
| Missing |
2041 (100%) |
0 (0%) |
|
| as.factor(lewybodydis_cat) |
|
|
|
| 1 |
0 (0%) |
656 (78.4%) |
NA |
| 1.5 |
0 (0%) |
1 (0.1%) |
|
| 2 |
0 (0%) |
39 (4.7%) |
|
| 3 |
0 (0%) |
28 (3.3%) |
|
| 4 |
0 (0%) |
38 (4.5%) |
|
| 5 |
0 (0%) |
5 (0.6%) |
|
| 6 |
0 (0%) |
70 (8.4%) |
|
| Missing |
2041 (100%) |
0 (0%) |
|
| LATE |
|
|
|
| 0 |
0 (0%) |
429 (51.3%) |
NA |
| 1 |
0 (0%) |
387 (46.2%) |
|
| Missing |
2041 (100%) |
21 (2.5%) |
|
| as.factor(late_stg) |
|
|
|
| 0 |
0 (0%) |
429 (51.3%) |
NA |
| 1 |
0 (0%) |
176 (21.0%) |
|
| 2 |
0 (0%) |
199 (23.8%) |
|
| 3 |
0 (0%) |
12 (1.4%) |
|
| Missing |
2041 (100%) |
21 (2.5%) |
|
| APOE Status |
|
|
|
| - APOE e4 |
1292 (63.3%) |
585 (69.9%) |
0.382 |
| + APOE e4 |
455 (22.3%) |
225 (26.9%) |
|
| Missing |
294 (14.4%) |
27 (3.2%) |
|
| Thal Phase |
|
|
|
| 0 |
0 (0%) |
50 (6.0%) |
NA |
| 1 |
0 (0%) |
34 (4.1%) |
|
| 2 |
0 (0%) |
37 (4.4%) |
|
| 3 |
0 (0%) |
86 (10.3%) |
|
| 4 |
0 (0%) |
107 (12.8%) |
|
| 5 |
0 (0%) |
65 (7.8%) |
|
| Missing |
2041 (100%) |
458 (54.7%) |
|
Table for for LBD
## Warning in chisq.test(table(y, g)): Chi-squared approximation may be incorrect
## Warning in chisq.test(table(y, g)): Chi-squared approximation may be incorrect
## Warning in chisq.test(table(y, g)): Chi-squared approximation may be incorrect
## Warning in chisq.test(table(y, g)): Chi-squared approximation may be incorrect
|
0 (N=657) |
1 (N=180) |
P-value |
| Cohort |
|
|
|
| Original |
415 (63.2%) |
91 (50.6%) |
0.008 |
| Expansion |
142 (21.6%) |
50 (27.8%) |
|
| Replacement |
100 (15.2%) |
39 (21.7%) |
|
| Gender |
|
|
|
| Female |
378 (57.5%) |
103 (57.2%) |
1 |
| Male |
279 (42.5%) |
77 (42.8%) |
|
| Age at Death |
|
|
|
| Mean (SD) |
89.0 (6.76) |
89.6 (6.27) |
0.278 |
| Median [Min, Max] |
89.6 [68.9, 106] |
90.4 [74.6, 102] |
|
| Year of Death |
|
|
|
| Mean (SD) |
2010 (5.91) |
2010 (5.86) |
<0.001 |
| Median [Min, Max] |
2010 [2000, 2020] |
2010 [2000, 2020] |
|
| race_cat_simp_adjusted |
|
|
|
| Non-White |
43 (6.5%) |
6 (3.3%) |
0.148 |
| White |
614 (93.5%) |
174 (96.7%) |
|
| APOE_adjusted_no |
|
|
|
| - APOE e4 |
490 (74.6%) |
122 (67.8%) |
0.084 |
| + APOE e4 |
167 (25.4%) |
58 (32.2%) |
|
| Ever Smoker |
|
|
|
| No |
281 (42.8%) |
96 (53.3%) |
0.015 |
| Yes |
376 (57.2%) |
84 (46.7%) |
|
| alcohol_cat_adjusted |
|
|
|
| Never |
117 (17.8%) |
38 (21.1%) |
0.008 |
| Former |
184 (28.0%) |
30 (16.7%) |
|
| Current |
356 (54.2%) |
112 (62.2%) |
|
| exercise_cat_adjusted |
|
|
|
| No |
195 (29.7%) |
54 (30.0%) |
1 |
| Yes |
462 (70.3%) |
126 (70.0%) |
|
| Education |
|
|
|
| Less than High School |
55 (8.4%) |
10 (5.6%) |
0.081 |
| GED |
10 (1.5%) |
2 (1.1%) |
|
| High School |
280 (42.6%) |
61 (33.9%) |
|
| Bachelor's |
144 (21.9%) |
54 (30.0%) |
|
| Master's |
89 (13.5%) |
22 (12.2%) |
|
| Doctorate |
33 (5.0%) |
13 (7.2%) |
|
| Other |
46 (7.0%) |
18 (10.0%) |
|
| education_cat_adjusted |
|
|
|
| < 13 |
202 (30.7%) |
41 (22.8%) |
0.112 |
| 13-16 |
278 (42.3%) |
86 (47.8%) |
|
| 17+ |
177 (26.9%) |
53 (29.4%) |
|
| nses_z_cx_adjusted |
|
|
|
| Mean (SD) |
-0.710 (0.701) |
-0.627 (0.737) |
0.18 |
| Median [Min, Max] |
-0.841 [-2.66, 2.47] |
-0.725 [-2.43, 1.20] |
|
| PM2.5 Exposure from Death (10 year) |
|
|
|
| Mean (SD) |
8.11 (1.65) |
7.49 (1.60) |
<0.001 |
| Median [Min, Max] |
7.94 [4.51, 14.3] |
6.95 [4.03, 14.6] |
|
| NO2 Exposure from Death (10 year) |
|
|
|
| Mean (SD) |
13.5 (3.53) |
13.0 (3.45) |
0.143 |
| Median [Min, Max] |
12.8 [4.88, 30.7] |
12.4 [5.61, 26.9] |
|
| Heart_Dis |
|
|
|
| No |
439 (66.8%) |
131 (72.8%) |
0.265 |
| Yes |
202 (30.7%) |
48 (26.7%) |
|
| Missing |
16 (2.4%) |
1 (0.6%) |
|
| Hypertension |
|
|
|
| No |
241 (36.7%) |
83 (46.1%) |
0.042 |
| Yes |
400 (60.9%) |
96 (53.3%) |
|
| Missing |
16 (2.4%) |
1 (0.6%) |
|
| Diabetes |
|
|
|
| No |
534 (81.3%) |
156 (86.7%) |
0.259 |
| Yes |
107 (16.3%) |
23 (12.8%) |
|
| Missing |
16 (2.4%) |
1 (0.6%) |
|
| bmi_adjusted |
|
|
|
| Mean (SD) |
26.9 (4.78) |
26.8 (4.64) |
0.745 |
| Median [Min, Max] |
26.3 [15.9, 48.9] |
26.3 [16.6, 46.8] |
|
| Dementia Status |
|
|
|
| No Dementia |
382 (58.1%) |
74 (41.1%) |
<0.001 |
| Dementia |
275 (41.9%) |
106 (58.9%) |
|
| Arrhythmia |
|
|
|
| No |
421 (64.1%) |
128 (71.1%) |
0.095 |
| Yes |
236 (35.9%) |
52 (28.9%) |
|
| CV_DIS_adj |
|
|
|
| 1 |
581 (88.4%) |
160 (88.9%) |
0.969 |
| 2 |
76 (11.6%) |
20 (11.1%) |
|
| Marital Status |
|
|
|
| Married |
348 (53.0%) |
106 (58.9%) |
0.184 |
| Not Married |
309 (47.0%) |
74 (41.1%) |
|
| Hipposcampal Sclerosis |
|
|
|
| 0 |
557 (84.8%) |
135 (75.0%) |
0.127 |
| 1 |
91 (13.9%) |
32 (17.8%) |
|
| Missing |
9 (1.4%) |
13 (7.2%) |
|
| as.factor(Hippocampal_Sclerosis) |
|
|
|
| Bilateral |
3 (0.5%) |
4 (2.2%) |
0.01 |
| Missing/Unknown |
15 (2.3%) |
1 (0.6%) |
|
| None |
557 (84.8%) |
135 (75.0%) |
|
| Present, but laterality not assessed |
67 (10.2%) |
22 (12.2%) |
|
| Unilateral |
6 (0.9%) |
5 (2.8%) |
|
| Missing |
9 (1.4%) |
13 (7.2%) |
|
| LATE |
|
|
|
| 0 |
361 (54.9%) |
68 (37.8%) |
<0.001 |
| 1 |
276 (42.0%) |
111 (61.7%) |
|
| Missing |
20 (3.0%) |
1 (0.6%) |
|
| as.factor(late_stg) |
|
|
|
| 0 |
361 (54.9%) |
68 (37.8%) |
<0.001 |
| 1 |
130 (19.8%) |
46 (25.6%) |
|
| 2 |
139 (21.2%) |
60 (33.3%) |
|
| 3 |
7 (1.1%) |
5 (2.8%) |
|
| Missing |
20 (3.0%) |
1 (0.6%) |
|
| APOE Status |
|
|
|
| - APOE e4 |
468 (71.2%) |
117 (65.0%) |
0.09 |
| + APOE e4 |
167 (25.4%) |
58 (32.2%) |
|
| Missing |
22 (3.3%) |
5 (2.8%) |
|
| as.factor(lewybodydis_cat) |
|
|
|
| 1 |
656 (99.8%) |
0 (0%) |
<0.001 |
| 1.5 |
1 (0.2%) |
0 (0%) |
|
| 2 |
0 (0%) |
39 (21.7%) |
|
| 3 |
0 (0%) |
28 (15.6%) |
|
| 4 |
0 (0%) |
38 (21.1%) |
|
| 5 |
0 (0%) |
5 (2.8%) |
|
| 6 |
0 (0%) |
70 (38.9%) |
|
|
LBP- and clinical diagnosis (N=275) |
LBP- and no clinical diagnosis (N=382) |
LBP+ and clinical diagnosis (N=106) |
LBP+ and no clinical diagnosis (N=74) |
Overall (N=837) |
| CERAD_cat_ordered |
|
|
|
|
|
| None |
38 (13.8%) |
125 (32.7%) |
8 (7.5%) |
15 (20.3%) |
186 (22.2%) |
| Sparse |
50 (18.2%) |
108 (28.3%) |
17 (16.0%) |
27 (36.5%) |
202 (24.1%) |
| Moderate |
74 (26.9%) |
80 (20.9%) |
24 (22.6%) |
17 (23.0%) |
195 (23.3%) |
| Frequent |
112 (40.7%) |
61 (16.0%) |
50 (47.2%) |
12 (16.2%) |
235 (28.1%) |
| Missing |
1 (0.4%) |
8 (2.1%) |
7 (6.6%) |
3 (4.1%) |
19 (2.3%) |
| Braak_cat_ordered |
|
|
|
|
|
| 0 |
5 (1.8%) |
17 (4.5%) |
1 (0.9%) |
1 (1.4%) |
24 (2.9%) |
| B1 |
33 (12.0%) |
145 (38.0%) |
6 (5.7%) |
17 (23.0%) |
201 (24.0%) |
| B2 |
75 (27.3%) |
146 (38.2%) |
28 (26.4%) |
38 (51.4%) |
287 (34.3%) |
| B3 |
161 (58.5%) |
62 (16.2%) |
63 (59.4%) |
14 (18.9%) |
300 (35.8%) |
| Missing |
1 (0.4%) |
12 (3.1%) |
8 (7.5%) |
4 (5.4%) |
25 (3.0%) |
##
## None Sparse Moderate Frequent
## 0 5 1 0 0
## 1 3 6 0 1
## 2 8 14 4 3
## 3 9 14 12 6
## 4 14 16 17 14
## 5 4 7 38 51
## 6 3 8 19 69
##
## None Sparse Moderate Frequent
## 0 11 3 3 0
## 1 27 19 8 1
## 2 38 34 16 16
## 3 33 37 24 6
## 4 26 28 19 10
## 5 3 10 21 27
## 6 1 1 2 9
Correlation across outcomes
HS vs. LBD
##
## LBD: No LBD: Yes
## HS: No 557 135
## HS: Yes 91 32
HS vs. LATE
##
## LATE: No LATE: Yes
## HS: No 396 280
## HS: Yes 23 95
LBD vs. LATE
##
## LATE: No LATE: Yes
## LBD: No 361 276
## LBD: Yes 68 111
Outcomes by Modifier
By sex
|
Female (N=481) |
Male (N=356) |
P-value |
| Hipposcampal Sclerosis |
|
|
|
| 0 |
399 (83.0%) |
293 (82.3%) |
0.956 |
| 1 |
70 (14.6%) |
53 (14.9%) |
|
| Missing |
12 (2.5%) |
10 (2.8%) |
|
| Lewy Body Disease |
|
|
|
| 0 |
378 (78.6%) |
279 (78.4%) |
1 |
| 1 |
103 (21.4%) |
77 (21.6%) |
|
| LATE |
|
|
|
| 0 |
242 (50.3%) |
187 (52.5%) |
0.564 |
| 1 |
227 (47.2%) |
160 (44.9%) |
|
| Missing |
12 (2.5%) |
9 (2.5%) |
|
By smoking
|
No (N=377) |
Yes (N=460) |
P-value |
| Hipposcampal Sclerosis |
|
|
|
| 0 |
305 (80.9%) |
387 (84.1%) |
0.385 |
| 1 |
60 (15.9%) |
63 (13.7%) |
|
| Missing |
12 (3.2%) |
10 (2.2%) |
|
| Lewy Body Disease |
|
|
|
| 0 |
281 (74.5%) |
376 (81.7%) |
0.015 |
| 1 |
96 (25.5%) |
84 (18.3%) |
|
| LATE |
|
|
|
| 0 |
185 (49.1%) |
244 (53.0%) |
0.204 |
| 1 |
185 (49.1%) |
202 (43.9%) |
|
| Missing |
7 (1.9%) |
14 (3.0%) |
|
By age group (< 90 or 90+)
|
< 90 (N=432) |
90+ (N=405) |
P-value |
| Hipposcampal Sclerosis |
|
|
|
| 0 |
372 (86.1%) |
320 (79.0%) |
0.01 |
| 1 |
50 (11.6%) |
73 (18.0%) |
|
| Missing |
10 (2.3%) |
12 (3.0%) |
|
| Lewy Body Disease |
|
|
|
| 0 |
343 (79.4%) |
314 (77.5%) |
0.567 |
| 1 |
89 (20.6%) |
91 (22.5%) |
|
| LATE |
|
|
|
| 0 |
251 (58.1%) |
178 (44.0%) |
<0.001 |
| 1 |
165 (38.2%) |
222 (54.8%) |
|
| Missing |
16 (3.7%) |
5 (1.2%) |
|
Table 1 for IPW variables
|
No (N=2041) |
Yes (N=837) |
P-value |
| Age at Death |
|
|
|
| Mean (SD) |
86.6 (7.18) |
89.2 (6.65) |
<0.001 |
| Median [Min, Max] |
87.2 [66.4, 108] |
89.7 [68.9, 106] |
|
| Cohort |
|
|
|
| Original |
1431 (70.1%) |
506 (60.5%) |
<0.001 |
| Expansion |
339 (16.6%) |
192 (22.9%) |
|
| Replacement |
271 (13.3%) |
139 (16.6%) |
|
| Gender |
|
|
|
| Female |
1139 (55.8%) |
481 (57.5%) |
0.439 |
| Male |
902 (44.2%) |
356 (42.5%) |
|
| Race |
|
|
|
| Non-White |
220 (10.8%) |
49 (5.9%) |
<0.001 |
| White |
1820 (89.2%) |
788 (94.1%) |
|
| Missing |
1 (0.0%) |
0 (0%) |
|
| NDI |
|
|
|
| Mean (SD) |
-0.655 (0.720) |
-0.692 (0.714) |
0.217 |
| Median [Min, Max] |
-0.782 [-2.66, 2.64] |
-0.805 [-2.66, 2.47] |
|
| Missing |
26 (1.3%) |
12 (1.4%) |
|
| education_cat |
|
|
|
| < 13 |
815 (39.9%) |
243 (29.0%) |
<0.001 |
| 13-16 |
850 (41.6%) |
364 (43.5%) |
|
| 17+ |
375 (18.4%) |
230 (27.5%) |
|
| Missing |
1 (0.0%) |
0 (0%) |
|
| Dementia Status |
|
|
|
| No Dementia |
1363 (66.8%) |
456 (54.5%) |
<0.001 |
| Dementia |
678 (33.2%) |
381 (45.5%) |
|
| Marital Status |
|
|
|
| Married |
1051 (51.5%) |
454 (54.2%) |
0.194 |
| Not Married |
990 (48.5%) |
383 (45.8%) |
|
Primary Models
hs_mod1_pm25_primary <- glm(HS_bi ~
exp_avgdeath_10_yr_ST_pm25_iqr +
age_death_yrs_centered +
male_cat,
data = autopsy_dead, weights = ipw_final_truncated,family = "binomial")
hs_mod2_pm25_primary <- glm(HS_bi ~
exp_avgdeath_10_yr_ST_pm25_iqr +
age_death_yrs_centered +
male_cat +
race_cat_simp +
nses_z_cx +
splines::bs(death_year_centered) +
apoe +
cohort_cat +
degree_cat,
data = autopsy_dead, weights = ipw_final_truncated,family = "binomial")
hs_mod3_pm25_primary <- glm(HS_bi ~
exp_avgdeath_10_yr_ST_pm25_iqr +
age_death_yrs_centered +
male_cat +
race_cat_simp +
nses_z_cx +
splines::bs(death_year_centered) +
apoe +
smoke_bi_adjusted +
exercise_cat +
alcohol_cat +
cohort_cat +
degree_cat +
bmi +
diabetes_cat_tv +
HTN_cat_tv +
Heart_Dis_tv,
data = autopsy_dead, weights = ipw_final_truncated,family = "binomial")
hs_mod2_pm25_htnmod<- glm(HS_bi ~
exp_avgdeath_10_yr_ST_pm25_iqr*male_cat +
age_death_yrs_centered +
race_cat_simp +
nses_z_cx +
splines::bs(death_year_centered) +
apoe +
cohort_cat +
education_cat,
data = autopsy_dead, weights = ipw_final_90l_truncated,family = "binomial")
hs_mod2_pm25_htnmod<- glm(HS_bi ~
exp_avgdeath_10_yr_ST_pm25_iqr*smoke_bi_adjusted +
age_death_yrs_centered +
race_cat_simp +
nses_z_cx +
splines::bs(death_year_centered) +
apoe +
cohort_cat +
education_cat,
data = autopsy_dead, weights = ipw_final_90l_truncated,family = "binomial")
Aim 1: Lewy Body Pathologies
Hippocampal sclerosis
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.021
|
0.000 – 17.161
|
0.270
|
0.024
|
0.000 – 0.725
|
0.049
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.012
|
0.861 – 1.189
|
0.882
|
|
|
|
|
splines::bs(age_death_yrs_centered)1
|
34.288
|
0.049 – 87508.661
|
0.330
|
32.953
|
0.048 – 81423.848
|
0.333
|
|
splines::bs(age_death_yrs_centered)2
|
0.743
|
0.050 – 11.498
|
0.829
|
0.716
|
0.048 – 11.078
|
0.808
|
|
splines::bs(age_death_yrs_centered)3
|
162.348
|
1.128 – 53323.076
|
0.060
|
152.834
|
1.078 – 49182.859
|
0.062
|
|
Gender: Male
|
1.432
|
0.924 – 2.219
|
0.108
|
1.439
|
0.928 – 2.231
|
0.103
|
|
race_cat_simp_adjustedWhite
|
0.841
|
0.413 – 1.880
|
0.650
|
0.853
|
0.418 – 1.912
|
0.679
|
|
nses z cx adjusted
|
0.906
|
0.657 – 1.239
|
0.540
|
0.891
|
0.651 – 1.213
|
0.468
|
|
splines::bs(death_year_centered)1
|
0.930
|
0.003 – 295.745
|
0.980
|
0.709
|
0.006 – 113.643
|
0.891
|
|
splines::bs(death_year_centered)2
|
0.073
|
0.003 – 1.651
|
0.101
|
0.062
|
0.010 – 0.407
|
0.003
|
|
splines::bs(death_year_centered)3
|
2.545
|
0.028 – 246.407
|
0.686
|
2.132
|
0.139 – 39.493
|
0.598
|
APOE adjusted no: +APOE e 4
|
1.462
|
0.919 – 2.295
|
0.103
|
1.461
|
0.919 – 2.292
|
0.103
|
|
Cohort: Expansion
|
1.492
|
0.852 – 2.563
|
0.153
|
1.439
|
0.816 – 2.492
|
0.200
|
|
Cohort: Replacement
|
0.717
|
0.323 – 1.506
|
0.395
|
0.708
|
0.319 – 1.487
|
0.376
|
|
education_cat_adjusted13-16
|
1.288
|
0.796 – 2.101
|
0.306
|
1.262
|
0.778 – 2.065
|
0.348
|
|
education_cat_adjusted17+
|
1.094
|
0.587 – 2.005
|
0.773
|
1.063
|
0.568 – 1.956
|
0.845
|
|
Ever Smoker: Yes
|
0.857
|
0.554 – 1.327
|
0.487
|
0.853
|
0.551 – 1.322
|
0.474
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.048
|
0.930 – 1.172
|
0.423
|
|
Observations
|
815
|
815
|
|
R2 Tjur
|
0.060
|
0.061
|
Stratified, PM2.5
|
Â
|
< 90
|
90+
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.000
|
0.000 – 0.777
|
0.073
|
2.330
|
0.000 – 9495.515
|
0.843
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.066
|
0.834 – 1.349
|
0.602
|
0.975
|
0.778 – 1.231
|
0.827
|
|
splines::bs(age_death_yrs_centered)1
|
602092.689
|
0.520 – 145025278868556.188
|
0.123
|
0.646
|
0.019 – 26.025
|
0.812
|
|
splines::bs(age_death_yrs_centered)2
|
98.420
|
0.186 – 1614451.492
|
0.262
|
3.034
|
0.029 – 210.917
|
0.616
|
|
splines::bs(age_death_yrs_centered)3
|
4719.672
|
1.054 – 1109268272.725
|
0.116
|
10.777
|
0.030 – 13318.364
|
0.443
|
|
Gender: Male
|
1.643
|
0.853 – 3.208
|
0.140
|
1.420
|
0.785 – 2.556
|
0.243
|
|
race_cat_simp_adjustedWhite
|
0.613
|
0.234 – 1.812
|
0.342
|
1.347
|
0.467 – 4.933
|
0.612
|
|
nses z cx adjusted
|
0.890
|
0.544 – 1.438
|
0.637
|
0.920
|
0.606 – 1.375
|
0.689
|
|
splines::bs(death_year_centered)1
|
23.461
|
0.006 – 139119.244
|
0.465
|
0.007
|
0.000 – 6.905
|
0.147
|
|
splines::bs(death_year_centered)2
|
0.088
|
0.001 – 7.931
|
0.299
|
0.042
|
0.001 – 2.717
|
0.132
|
|
splines::bs(death_year_centered)3
|
33.101
|
0.031 – 36221.880
|
0.323
|
0.163
|
0.001 – 45.650
|
0.522
|
APOE adjusted no: +APOE e 4
|
1.016
|
0.492 – 2.014
|
0.965
|
2.344
|
1.257 – 4.315
|
0.007
|
|
Cohort: Expansion
|
1.362
|
0.530 – 3.309
|
0.505
|
1.430
|
0.705 – 2.818
|
0.309
|
|
Cohort: Replacement
|
0.533
|
0.123 – 2.021
|
0.373
|
0.669
|
0.234 – 1.694
|
0.420
|
|
education_cat_adjusted13-16
|
1.468
|
0.685 – 3.261
|
0.330
|
1.156
|
0.621 – 2.166
|
0.648
|
|
education_cat_adjusted17+
|
1.638
|
0.642 – 4.173
|
0.298
|
0.778
|
0.330 – 1.743
|
0.551
|
|
Ever Smoker: Yes
|
0.913
|
0.464 – 1.819
|
0.792
|
0.748
|
0.417 – 1.336
|
0.327
|
|
Observations
|
422
|
393
|
|
R2 Tjur
|
0.038
|
0.081
|
Stratified, NO2
|
Â
|
< 90
|
90+
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.000
|
0.000 – 0.143
|
0.052
|
0.499
|
0.014 – 15.817
|
0.693
|
NO 2 Exposure from Death(10 year,IQR)
|
1.018
|
0.830 – 1.219
|
0.855
|
1.065
|
0.910 – 1.234
|
0.413
|
|
splines::bs(age_death_yrs_centered)1
|
611270.113
|
0.620 – 133194742874604.422
|
0.118
|
0.732
|
0.021 – 29.824
|
0.865
|
|
splines::bs(age_death_yrs_centered)2
|
98.065
|
0.197 – 1572278.563
|
0.258
|
2.458
|
0.023 – 174.132
|
0.686
|
|
splines::bs(age_death_yrs_centered)3
|
4604.565
|
1.129 – 1025787835.592
|
0.113
|
12.233
|
0.034 – 15233.279
|
0.419
|
|
Gender: Male
|
1.646
|
0.853 – 3.219
|
0.139
|
1.454
|
0.802 – 2.626
|
0.214
|
|
race_cat_simp_adjustedWhite
|
0.636
|
0.247 – 1.860
|
0.373
|
1.472
|
0.507 – 5.468
|
0.515
|
|
nses z cx adjusted
|
0.912
|
0.564 – 1.464
|
0.705
|
0.883
|
0.587 – 1.316
|
0.545
|
|
splines::bs(death_year_centered)1
|
6.480
|
0.007 – 10839.287
|
0.606
|
0.010
|
0.000 – 5.722
|
0.139
|
|
splines::bs(death_year_centered)2
|
0.034
|
0.002 – 0.525
|
0.016
|
0.065
|
0.006 – 0.813
|
0.030
|
|
splines::bs(death_year_centered)3
|
7.763
|
0.121 – 685.753
|
0.349
|
0.341
|
0.011 – 11.982
|
0.532
|
APOE adjusted no: +APOE e 4
|
1.035
|
0.503 – 2.045
|
0.923
|
2.360
|
1.264 – 4.353
|
0.006
|
|
Cohort: Expansion
|
1.362
|
0.524 – 3.346
|
0.510
|
1.382
|
0.677 – 2.739
|
0.362
|
|
Cohort: Replacement
|
0.534
|
0.124 – 2.019
|
0.374
|
0.645
|
0.226 – 1.634
|
0.380
|
|
education_cat_adjusted13-16
|
1.459
|
0.677 – 3.256
|
0.342
|
1.128
|
0.603 – 2.121
|
0.707
|
|
education_cat_adjusted17+
|
1.624
|
0.632 – 4.164
|
0.310
|
0.740
|
0.311 – 1.678
|
0.482
|
|
Ever Smoker: Yes
|
0.920
|
0.467 – 1.833
|
0.809
|
0.757
|
0.423 – 1.350
|
0.345
|
|
Observations
|
422
|
393
|
|
R2 Tjur
|
0.037
|
0.084
|
Lewy Body Disease
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.002
|
0.000 – 0.764
|
0.045
|
0.006
|
0.000 – 0.177
|
0.006
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.033
|
0.897 – 1.188
|
0.653
|
|
|
|
|
splines::bs(age_death_yrs_centered)1
|
238.431
|
0.463 – 284173.255
|
0.105
|
247.182
|
0.484 – 291439.500
|
0.102
|
|
splines::bs(age_death_yrs_centered)2
|
1.996
|
0.174 – 24.890
|
0.582
|
1.960
|
0.171 – 24.400
|
0.592
|
|
splines::bs(age_death_yrs_centered)3
|
24.280
|
0.166 – 5149.473
|
0.220
|
24.848
|
0.171 – 5237.598
|
0.216
|
|
Gender: Male
|
1.276
|
0.871 – 1.867
|
0.210
|
1.281
|
0.874 – 1.874
|
0.203
|
|
race_cat_simp_adjustedWhite
|
4.197
|
1.841 – 11.419
|
0.002
|
4.200
|
1.842 – 11.424
|
0.002
|
|
nses z cx adjusted
|
1.245
|
0.949 – 1.632
|
0.112
|
1.256
|
0.961 – 1.642
|
0.095
|
|
splines::bs(death_year_centered)1
|
0.284
|
0.002 – 44.698
|
0.620
|
0.170
|
0.002 – 17.614
|
0.441
|
|
splines::bs(death_year_centered)2
|
0.628
|
0.041 – 9.726
|
0.738
|
0.382
|
0.075 – 2.104
|
0.254
|
|
splines::bs(death_year_centered)3
|
5.306
|
0.112 – 266.288
|
0.399
|
2.750
|
0.237 – 38.180
|
0.433
|
APOE adjusted no: +APOE e 4
|
1.638
|
1.097 – 2.431
|
0.015
|
1.644
|
1.101 – 2.439
|
0.014
|
|
Cohort: Expansion
|
1.219
|
0.743 – 1.971
|
0.424
|
1.208
|
0.733 – 1.962
|
0.451
|
|
Cohort: Replacement
|
0.975
|
0.527 – 1.776
|
0.934
|
0.976
|
0.527 – 1.780
|
0.937
|
|
education_cat_adjusted13-16
|
1.301
|
0.854 – 1.995
|
0.223
|
1.292
|
0.846 – 1.984
|
0.238
|
|
education_cat_adjusted17+
|
1.042
|
0.608 – 1.768
|
0.880
|
1.029
|
0.599 – 1.750
|
0.917
|
|
Ever Smoker: Yes
|
0.650
|
0.445 – 0.946
|
0.024
|
0.648
|
0.444 – 0.944
|
0.024
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.012
|
0.910 – 1.119
|
0.821
|
|
Observations
|
837
|
837
|
|
R2 Tjur
|
0.078
|
0.078
|
Stratified, PM2.5
|
Â
|
< 90
|
90+
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.000
|
0.000 – 0.021
|
0.019
|
0.049
|
0.000 – 157.148
|
0.473
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.056
|
0.866 – 1.283
|
0.586
|
0.960
|
0.780 – 1.185
|
0.703
|
|
splines::bs(age_death_yrs_centered)1
|
206041967.156
|
31.825 – 163023557614116064.000
|
0.039
|
0.104
|
0.001 – 5.882
|
0.301
|
|
splines::bs(age_death_yrs_centered)2
|
39829.366
|
24.146 – 2017572770.536
|
0.023
|
482.082
|
0.498 – 7804890.746
|
0.164
|
|
splines::bs(age_death_yrs_centered)3
|
247236.754
|
13.155 – 181464121102.330
|
0.038
|
0.000
|
0.000 – 0.738
|
0.168
|
|
Gender: Male
|
1.186
|
0.678 – 2.074
|
0.549
|
1.309
|
0.766 – 2.231
|
0.322
|
|
race_cat_simp_adjustedWhite
|
4.162
|
1.421 – 15.920
|
0.018
|
3.769
|
1.037 – 23.128
|
0.080
|
|
nses z cx adjusted
|
1.269
|
0.837 – 1.925
|
0.261
|
1.184
|
0.820 – 1.699
|
0.361
|
|
splines::bs(death_year_centered)1
|
0.051
|
0.000 – 54.937
|
0.397
|
7.295
|
0.003 – 151567.408
|
0.656
|
|
splines::bs(death_year_centered)2
|
0.719
|
0.018 – 27.197
|
0.859
|
0.568
|
0.009 – 61.943
|
0.800
|
|
splines::bs(death_year_centered)3
|
2.544
|
0.010 – 642.956
|
0.740
|
13.672
|
0.047 – 9938.344
|
0.397
|
APOE adjusted no: +APOE e 4
|
2.057
|
1.175 – 3.599
|
0.011
|
1.314
|
0.694 – 2.422
|
0.389
|
|
Cohort: Expansion
|
1.149
|
0.515 – 2.468
|
0.726
|
1.422
|
0.746 – 2.657
|
0.276
|
|
Cohort: Replacement
|
1.285
|
0.476 – 3.402
|
0.616
|
0.691
|
0.274 – 1.612
|
0.410
|
|
education_cat_adjusted13-16
|
1.054
|
0.564 – 1.985
|
0.871
|
1.672
|
0.931 – 3.048
|
0.088
|
|
education_cat_adjusted17+
|
0.955
|
0.442 – 2.032
|
0.906
|
0.966
|
0.437 – 2.074
|
0.930
|
|
Ever Smoker: Yes
|
0.640
|
0.365 – 1.117
|
0.116
|
0.698
|
0.409 – 1.184
|
0.183
|
|
Observations
|
432
|
405
|
|
R2 Tjur
|
0.096
|
0.096
|
Stratified, NO2
|
Â
|
< 90
|
90+
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.000
|
0.000 – 0.013
|
0.017
|
0.010
|
0.000 – 0.754
|
0.070
|
NO 2 Exposure from Death(10 year,IQR)
|
1.021
|
0.868 – 1.185
|
0.795
|
1.027
|
0.883 – 1.184
|
0.715
|
|
splines::bs(age_death_yrs_centered)1
|
243213284.000
|
37.861 – 205091421695235232.000
|
0.038
|
0.113
|
0.001 – 6.270
|
0.316
|
|
splines::bs(age_death_yrs_centered)2
|
45423.558
|
27.318 – 2411981707.975
|
0.022
|
407.867
|
0.442 – 6172570.694
|
0.172
|
|
splines::bs(age_death_yrs_centered)3
|
272582.235
|
14.436 – 210523622439.938
|
0.037
|
0.000
|
0.000 – 0.797
|
0.170
|
|
Gender: Male
|
1.190
|
0.680 – 2.085
|
0.542
|
1.330
|
0.774 – 2.279
|
0.299
|
|
race_cat_simp_adjustedWhite
|
4.169
|
1.431 – 15.876
|
0.018
|
3.947
|
1.087 – 24.227
|
0.070
|
|
nses z cx adjusted
|
1.295
|
0.863 – 1.950
|
0.212
|
1.150
|
0.800 – 1.649
|
0.447
|
|
splines::bs(death_year_centered)1
|
0.019
|
0.000 – 9.374
|
0.200
|
11.892
|
0.008 – 216453.807
|
0.566
|
|
splines::bs(death_year_centered)2
|
0.316
|
0.037 – 2.787
|
0.292
|
1.025
|
0.056 – 53.731
|
0.988
|
|
splines::bs(death_year_centered)3
|
0.774
|
0.025 – 27.554
|
0.885
|
31.465
|
0.505 – 10856.201
|
0.168
|
APOE adjusted no: +APOE e 4
|
2.078
|
1.188 – 3.631
|
0.010
|
1.320
|
0.696 – 2.434
|
0.383
|
|
Cohort: Expansion
|
1.132
|
0.505 – 2.444
|
0.757
|
1.403
|
0.734 – 2.633
|
0.297
|
|
Cohort: Replacement
|
1.289
|
0.478 – 3.413
|
0.611
|
0.669
|
0.265 – 1.559
|
0.370
|
|
education_cat_adjusted13-16
|
1.044
|
0.557 – 1.972
|
0.893
|
1.669
|
0.929 – 3.045
|
0.090
|
|
education_cat_adjusted17+
|
0.942
|
0.434 – 2.010
|
0.877
|
0.956
|
0.430 – 2.066
|
0.909
|
|
Ever Smoker: Yes
|
0.642
|
0.366 – 1.121
|
0.119
|
0.706
|
0.415 – 1.195
|
0.195
|
|
Observations
|
432
|
405
|
|
R2 Tjur
|
0.096
|
0.097
|
LATE stage
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.079
|
0.000 – 10.457
|
0.317
|
0.016
|
0.001 – 0.283
|
0.009
|
PM 2.5 Exposure from Death(10 year,IQR)
|
0.965
|
0.860 – 1.081
|
0.539
|
|
|
|
|
splines::bs(age_death_yrs_centered)1
|
14.872
|
0.064 – 7913.821
|
0.363
|
13.929
|
0.061 – 7375.972
|
0.374
|
|
splines::bs(age_death_yrs_centered)2
|
47.353
|
5.741 – 394.312
|
<0.001
|
46.651
|
5.657 – 388.828
|
<0.001
|
|
splines::bs(age_death_yrs_centered)3
|
40.504
|
0.563 – 5235.309
|
0.109
|
36.508
|
0.511 – 4686.629
|
0.118
|
|
Gender: Male
|
1.130
|
0.829 – 1.540
|
0.440
|
1.130
|
0.830 – 1.541
|
0.438
|
|
race_cat_simp_adjustedWhite
|
1.258
|
0.744 – 2.155
|
0.395
|
1.275
|
0.752 – 2.188
|
0.370
|
|
nses z cx adjusted
|
0.924
|
0.740 – 1.151
|
0.481
|
0.885
|
0.711 – 1.100
|
0.273
|
|
splines::bs(death_year_centered)1
|
0.545
|
0.008 – 36.217
|
0.775
|
0.895
|
0.021 – 40.358
|
0.954
|
|
splines::bs(death_year_centered)2
|
0.510
|
0.057 – 4.499
|
0.544
|
0.887
|
0.230 – 3.468
|
0.862
|
|
splines::bs(death_year_centered)3
|
0.794
|
0.031 – 20.712
|
0.890
|
1.907
|
0.218 – 17.322
|
0.562
|
APOE adjusted no: +APOE e 4
|
1.606
|
1.151 – 2.245
|
0.005
|
1.602
|
1.149 – 2.240
|
0.006
|
|
Cohort: Expansion
|
0.934
|
0.622 – 1.399
|
0.740
|
0.900
|
0.596 – 1.355
|
0.614
|
|
Cohort: Replacement
|
0.816
|
0.485 – 1.366
|
0.440
|
0.791
|
0.470 – 1.326
|
0.376
|
|
education_cat_adjusted13-16
|
1.187
|
0.848 – 1.662
|
0.318
|
1.167
|
0.833 – 1.637
|
0.369
|
|
education_cat_adjusted17+
|
1.130
|
0.734 – 1.739
|
0.578
|
1.106
|
0.717 – 1.705
|
0.649
|
|
Ever Smoker: Yes
|
0.988
|
0.728 – 1.341
|
0.936
|
0.980
|
0.722 – 1.331
|
0.895
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.054
|
0.968 – 1.151
|
0.229
|
|
Observations
|
816
|
816
|
|
R2 Tjur
|
0.078
|
0.079
|
Stratified, PM2.5
|
Â
|
< 90
|
90+
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.050
|
0.000 – 63.732
|
0.429
|
1.714
|
0.004 – 783.949
|
0.862
|
PM 2.5 Exposure from Death(10 year,IQR)
|
0.969
|
0.820 – 1.142
|
0.704
|
0.954
|
0.809 – 1.123
|
0.572
|
|
splines::bs(age_death_yrs_centered)1
|
31.477
|
0.012 – 627289.875
|
0.438
|
0.330
|
0.024 – 4.392
|
0.402
|
|
splines::bs(age_death_yrs_centered)2
|
6.419
|
0.208 – 709.518
|
0.354
|
32.594
|
0.886 – 1426.227
|
0.059
|
|
splines::bs(age_death_yrs_centered)3
|
70.068
|
0.702 – 32695.997
|
0.112
|
0.069
|
0.000 – 16.862
|
0.327
|
|
Gender: Male
|
1.208
|
0.767 – 1.909
|
0.416
|
1.100
|
0.718 – 1.691
|
0.662
|
|
race_cat_simp_adjustedWhite
|
1.186
|
0.568 – 2.543
|
0.653
|
1.358
|
0.617 – 3.024
|
0.446
|
|
nses z cx adjusted
|
0.880
|
0.628 – 1.228
|
0.453
|
0.911
|
0.678 – 1.223
|
0.536
|
|
splines::bs(death_year_centered)1
|
0.196
|
0.000 – 81.570
|
0.595
|
2.512
|
0.012 – 690.236
|
0.739
|
|
splines::bs(death_year_centered)2
|
0.415
|
0.019 – 8.732
|
0.572
|
0.581
|
0.028 – 12.060
|
0.725
|
|
splines::bs(death_year_centered)3
|
0.767
|
0.006 – 91.364
|
0.913
|
1.471
|
0.022 – 103.739
|
0.857
|
APOE adjusted no: +APOE e 4
|
1.812
|
1.134 – 2.898
|
0.013
|
1.180
|
0.718 – 1.953
|
0.516
|
|
Cohort: Expansion
|
0.833
|
0.434 – 1.576
|
0.577
|
1.001
|
0.590 – 1.706
|
0.996
|
|
Cohort: Replacement
|
0.582
|
0.243 – 1.357
|
0.216
|
1.019
|
0.512 – 2.049
|
0.958
|
|
education_cat_adjusted13-16
|
1.394
|
0.840 – 2.329
|
0.201
|
0.947
|
0.600 – 1.492
|
0.815
|
|
education_cat_adjusted17+
|
1.538
|
0.811 – 2.931
|
0.188
|
0.769
|
0.429 – 1.375
|
0.375
|
|
Ever Smoker: Yes
|
1.082
|
0.684 – 1.721
|
0.737
|
0.877
|
0.576 – 1.333
|
0.539
|
|
Observations
|
416
|
400
|
|
R2 Tjur
|
0.104
|
0.029
|
Stratified, NO2
|
Â
|
< 90
|
90+
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.013
|
0.000 – 1.099
|
0.093
|
0.281
|
0.014 – 4.926
|
0.389
|
NO 2 Exposure from Death(10 year,IQR)
|
1.063
|
0.934 – 1.213
|
0.357
|
1.021
|
0.908 – 1.150
|
0.728
|
|
splines::bs(age_death_yrs_centered)1
|
24.227
|
0.010 – 435239.868
|
0.466
|
0.350
|
0.026 – 4.658
|
0.427
|
|
splines::bs(age_death_yrs_centered)2
|
6.141
|
0.208 – 651.486
|
0.359
|
29.718
|
0.799 – 1307.222
|
0.066
|
|
splines::bs(age_death_yrs_centered)3
|
59.329
|
0.640 – 26032.563
|
0.121
|
0.075
|
0.000 – 18.361
|
0.341
|
|
Gender: Male
|
1.185
|
0.751 – 1.874
|
0.466
|
1.108
|
0.722 – 1.706
|
0.639
|
|
race_cat_simp_adjustedWhite
|
1.162
|
0.558 – 2.485
|
0.692
|
1.424
|
0.651 – 3.155
|
0.376
|
|
nses z cx adjusted
|
0.843
|
0.605 – 1.168
|
0.306
|
0.882
|
0.657 – 1.182
|
0.402
|
|
splines::bs(death_year_centered)1
|
0.294
|
0.002 – 60.096
|
0.650
|
4.681
|
0.032 – 937.564
|
0.548
|
|
splines::bs(death_year_centered)2
|
0.656
|
0.104 – 4.153
|
0.653
|
1.180
|
0.170 – 8.673
|
0.868
|
|
splines::bs(death_year_centered)3
|
1.620
|
0.071 – 38.674
|
0.763
|
3.916
|
0.223 – 83.455
|
0.356
|
APOE adjusted no: +APOE e 4
|
1.806
|
1.132 – 2.887
|
0.013
|
1.187
|
0.722 – 1.966
|
0.501
|
|
Cohort: Expansion
|
0.798
|
0.411 – 1.521
|
0.497
|
0.989
|
0.579 – 1.692
|
0.967
|
|
Cohort: Replacement
|
0.574
|
0.239 – 1.341
|
0.206
|
0.992
|
0.498 – 1.996
|
0.983
|
|
education_cat_adjusted13-16
|
1.368
|
0.822 – 2.291
|
0.230
|
0.942
|
0.596 – 1.487
|
0.799
|
|
education_cat_adjusted17+
|
1.507
|
0.793 – 2.877
|
0.211
|
0.764
|
0.424 – 1.373
|
0.368
|
|
Ever Smoker: Yes
|
1.064
|
0.672 – 1.694
|
0.791
|
0.884
|
0.582 – 1.343
|
0.564
|
|
Observations
|
416
|
400
|
|
R2 Tjur
|
0.105
|
0.028
|
Aim 2: Modifying effect of sex and smoking
Outcome = Hippocampal sclerosis
Modifier = Sex
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.199
|
0.000 – 104.949
|
0.616
|
0.192
|
0.013 – 2.457
|
0.216
|
PM 2.5 Exposure from Death(10 year,IQR)
|
0.998
|
0.842 – 1.183
|
0.983
|
|
|
|
|
Gender: Male
|
0.819
|
0.116 – 5.679
|
0.840
|
0.956
|
0.185 – 4.963
|
0.957
|
|
Age at Death(centered)
|
1.056
|
1.019 – 1.096
|
0.003
|
1.055
|
1.018 – 1.095
|
0.004
|
|
race_cat_simp_adjustedWhite
|
0.871
|
0.428 – 1.952
|
0.719
|
0.893
|
0.435 – 2.015
|
0.770
|
|
nses z cx adjusted
|
0.895
|
0.650 – 1.225
|
0.495
|
0.882
|
0.644 – 1.201
|
0.429
|
|
splines::bs(death_year_centered)1
|
1.182
|
0.005 – 347.302
|
0.953
|
0.861
|
0.008 – 126.116
|
0.952
|
|
splines::bs(death_year_centered)2
|
0.066
|
0.003 – 1.494
|
0.088
|
0.056
|
0.009 – 0.357
|
0.002
|
|
splines::bs(death_year_centered)3
|
2.695
|
0.031 – 252.892
|
0.666
|
2.267
|
0.154 – 40.019
|
0.562
|
APOE adjusted no: +APOE e 4
|
1.466
|
0.924 – 2.296
|
0.098
|
1.476
|
0.931 – 2.311
|
0.092
|
|
Cohort: Expansion
|
1.514
|
0.867 – 2.593
|
0.137
|
1.474
|
0.838 – 2.544
|
0.169
|
|
Cohort: Replacement
|
0.762
|
0.345 – 1.589
|
0.482
|
0.751
|
0.340 – 1.567
|
0.459
|
|
education_cat_adjusted13-16
|
1.299
|
0.804 – 2.119
|
0.288
|
1.271
|
0.785 – 2.076
|
0.332
|
|
education_cat_adjusted17+
|
1.113
|
0.596 – 2.043
|
0.733
|
1.067
|
0.571 – 1.960
|
0.837
|
|
Ever Smoker: Yes
|
0.839
|
0.543 – 1.299
|
0.430
|
0.846
|
0.548 – 1.307
|
0.449
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:male_catMale
|
1.028
|
0.933 – 1.134
|
0.578
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.024
|
0.873 – 1.184
|
0.762
|
|
exp_avgdeath_10_yr_ST_no2_iqr:male_catMale
|
|
|
|
1.054
|
0.849 – 1.305
|
0.630
|
|
Observations
|
815
|
815
|
|
R2 Tjur
|
0.052
|
0.052
|
Modifier = Smoking
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.191
|
0.000 – 106.978
|
0.610
|
0.229
|
0.014 – 3.220
|
0.284
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.000
|
0.841 – 1.189
|
0.998
|
|
|
|
|
Ever Smoker: Yes
|
0.563
|
0.079 – 3.878
|
0.561
|
0.482
|
0.092 – 2.463
|
0.382
|
|
Age at Death(centered)
|
1.057
|
1.019 – 1.096
|
0.003
|
1.056
|
1.018 – 1.095
|
0.004
|
|
Gender: Male
|
1.387
|
0.895 – 2.147
|
0.142
|
1.407
|
0.910 – 2.174
|
0.124
|
|
race_cat_simp_adjustedWhite
|
0.858
|
0.422 – 1.919
|
0.690
|
0.864
|
0.424 – 1.933
|
0.702
|
|
nses z cx adjusted
|
0.896
|
0.650 – 1.226
|
0.496
|
0.889
|
0.650 – 1.209
|
0.456
|
|
splines::bs(death_year_centered)1
|
1.213
|
0.005 – 362.154
|
0.946
|
0.877
|
0.008 – 128.499
|
0.957
|
|
splines::bs(death_year_centered)2
|
0.066
|
0.003 – 1.507
|
0.089
|
0.055
|
0.009 – 0.353
|
0.002
|
|
splines::bs(death_year_centered)3
|
2.799
|
0.032 – 265.634
|
0.655
|
2.306
|
0.156 – 40.812
|
0.554
|
APOE adjusted no: +APOE e 4
|
1.473
|
0.928 – 2.306
|
0.095
|
1.460
|
0.920 – 2.286
|
0.102
|
|
Cohort: Expansion
|
1.525
|
0.874 – 2.612
|
0.129
|
1.473
|
0.837 – 2.543
|
0.170
|
|
Cohort: Replacement
|
0.761
|
0.345 – 1.589
|
0.480
|
0.746
|
0.338 – 1.557
|
0.449
|
|
education_cat_adjusted13-16
|
1.282
|
0.794 – 2.088
|
0.313
|
1.254
|
0.775 – 2.048
|
0.359
|
|
education_cat_adjusted17+
|
1.088
|
0.584 – 1.990
|
0.787
|
1.070
|
0.573 – 1.964
|
0.830
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:smoke_bi_adjustedYes
|
1.022
|
0.927 – 1.130
|
0.669
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.005
|
0.840 – 1.179
|
0.955
|
|
exp_avgdeath_10_yr_ST_no2_iqr:smoke_bi_adjustedYes
|
|
|
|
1.079
|
0.872 – 1.343
|
0.485
|
|
Observations
|
815
|
815
|
|
R2 Tjur
|
0.052
|
0.053
|
Modifier = APOE
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.104
|
0.000 – 54.243
|
0.481
|
0.229
|
0.014 – 3.220
|
0.284
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.029
|
0.874 – 1.212
|
0.732
|
|
|
|
APOE adjusted no: +APOE e 4
|
4.484
|
0.544 – 40.090
|
0.169
|
1.460
|
0.920 – 2.286
|
0.102
|
|
Ever Smoker: Yes
|
0.850
|
0.551 – 1.313
|
0.462
|
0.482
|
0.092 – 2.463
|
0.382
|
|
Age at Death(centered)
|
1.056
|
1.019 – 1.096
|
0.003
|
1.056
|
1.018 – 1.095
|
0.004
|
|
Gender: Male
|
1.410
|
0.912 – 2.179
|
0.121
|
1.407
|
0.910 – 2.174
|
0.124
|
|
race_cat_simp_adjustedWhite
|
0.872
|
0.429 – 1.953
|
0.721
|
0.864
|
0.424 – 1.933
|
0.702
|
|
nses z cx adjusted
|
0.902
|
0.654 – 1.236
|
0.526
|
0.889
|
0.650 – 1.209
|
0.456
|
|
splines::bs(death_year_centered)1
|
1.347
|
0.006 – 394.516
|
0.916
|
0.877
|
0.008 – 128.499
|
0.957
|
|
splines::bs(death_year_centered)2
|
0.066
|
0.003 – 1.508
|
0.089
|
0.055
|
0.009 – 0.353
|
0.002
|
|
splines::bs(death_year_centered)3
|
2.986
|
0.034 – 285.203
|
0.635
|
2.306
|
0.156 – 40.812
|
0.554
|
|
Cohort: Expansion
|
1.509
|
0.863 – 2.587
|
0.140
|
1.473
|
0.837 – 2.543
|
0.170
|
|
Cohort: Replacement
|
0.746
|
0.337 – 1.562
|
0.451
|
0.746
|
0.338 – 1.557
|
0.449
|
|
education_cat_adjusted13-16
|
1.288
|
0.798 – 2.098
|
0.303
|
1.254
|
0.775 – 2.048
|
0.359
|
|
education_cat_adjusted17+
|
1.101
|
0.591 – 2.016
|
0.758
|
1.070
|
0.573 – 1.964
|
0.830
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:APOE_adjusted_no+ APOE e4
|
0.944
|
0.843 – 1.049
|
0.299
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.005
|
0.840 – 1.179
|
0.955
|
|
exp_avgdeath_10_yr_ST_no2_iqr:smoke_bi_adjustedYes
|
|
|
|
1.079
|
0.872 – 1.343
|
0.485
|
|
Observations
|
815
|
815
|
|
R2 Tjur
|
0.053
|
0.053
|
Outcome = Lewy Body Disease category
Modifier = Sex
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.028
|
0.000 – 6.043
|
0.194
|
0.068
|
0.005 – 0.778
|
0.036
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.007
|
0.869 – 1.166
|
0.930
|
|
|
|
|
Gender: Male
|
0.507
|
0.089 – 2.815
|
0.440
|
0.760
|
0.181 – 3.195
|
0.706
|
|
Age at Death(centered)
|
0.999
|
0.968 – 1.031
|
0.951
|
1.000
|
0.968 – 1.032
|
0.980
|
|
race_cat_simp_adjustedWhite
|
4.157
|
1.823 – 11.312
|
0.002
|
4.166
|
1.822 – 11.356
|
0.002
|
|
nses z cx adjusted
|
1.236
|
0.943 – 1.620
|
0.124
|
1.250
|
0.956 – 1.635
|
0.102
|
|
splines::bs(death_year_centered)1
|
0.796
|
0.006 – 117.800
|
0.927
|
0.370
|
0.005 – 35.476
|
0.659
|
|
splines::bs(death_year_centered)2
|
0.807
|
0.054 – 12.442
|
0.877
|
0.472
|
0.094 – 2.589
|
0.372
|
|
splines::bs(death_year_centered)3
|
8.723
|
0.194 – 420.497
|
0.268
|
4.116
|
0.365 – 55.869
|
0.268
|
APOE adjusted no: +APOE e 4
|
1.676
|
1.125 – 2.483
|
0.010
|
1.694
|
1.137 – 2.509
|
0.009
|
|
Cohort: Expansion
|
1.240
|
0.758 – 2.002
|
0.384
|
1.252
|
0.762 – 2.031
|
0.367
|
|
Cohort: Replacement
|
0.967
|
0.525 – 1.755
|
0.914
|
0.963
|
0.522 – 1.750
|
0.904
|
|
education_cat_adjusted13-16
|
1.305
|
0.856 – 2.002
|
0.219
|
1.290
|
0.846 – 1.979
|
0.240
|
|
education_cat_adjusted17+
|
1.050
|
0.612 – 1.782
|
0.859
|
1.012
|
0.590 – 1.718
|
0.966
|
|
Ever Smoker: Yes
|
0.621
|
0.425 – 0.905
|
0.013
|
0.630
|
0.432 – 0.917
|
0.016
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:male_catMale
|
1.051
|
0.962 – 1.150
|
0.277
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
0.979
|
0.851 – 1.115
|
0.755
|
|
exp_avgdeath_10_yr_ST_no2_iqr:male_catMale
|
|
|
|
1.077
|
0.888 – 1.303
|
0.448
|
|
Observations
|
837
|
837
|
|
R2 Tjur
|
0.078
|
0.078
|
Modifier = Smoking
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.015
|
0.000 – 3.442
|
0.132
|
0.029
|
0.002 – 0.348
|
0.007
|
PM 2.5 Exposure from Death(10 year,IQR)
|
1.046
|
0.901 – 1.213
|
0.555
|
|
|
|
|
Ever Smoker: Yes
|
0.869
|
0.157 – 4.738
|
0.871
|
2.297
|
0.547 – 9.961
|
0.260
|
|
Age at Death(centered)
|
0.998
|
0.967 – 1.030
|
0.899
|
0.996
|
0.965 – 1.028
|
0.801
|
|
Gender: Male
|
1.298
|
0.886 – 1.899
|
0.180
|
1.299
|
0.888 – 1.901
|
0.177
|
|
race_cat_simp_adjustedWhite
|
4.020
|
1.770 – 10.902
|
0.002
|
4.067
|
1.786 – 11.040
|
0.002
|
|
nses z cx adjusted
|
1.245
|
0.949 – 1.631
|
0.112
|
1.244
|
0.950 – 1.629
|
0.112
|
|
splines::bs(death_year_centered)1
|
0.604
|
0.005 – 87.295
|
0.839
|
0.367
|
0.005 – 35.928
|
0.658
|
|
splines::bs(death_year_centered)2
|
0.804
|
0.054 – 12.247
|
0.874
|
0.472
|
0.093 – 2.605
|
0.374
|
|
splines::bs(death_year_centered)3
|
8.334
|
0.187 – 397.636
|
0.277
|
4.113
|
0.360 – 56.579
|
0.271
|
APOE adjusted no: +APOE e 4
|
1.682
|
1.129 – 2.491
|
0.010
|
1.737
|
1.164 – 2.577
|
0.006
|
|
Cohort: Expansion
|
1.255
|
0.767 – 2.023
|
0.358
|
1.240
|
0.753 – 2.013
|
0.391
|
|
Cohort: Replacement
|
0.951
|
0.516 – 1.725
|
0.870
|
0.955
|
0.517 – 1.735
|
0.881
|
|
education_cat_adjusted13-16
|
1.299
|
0.852 – 1.990
|
0.226
|
1.309
|
0.858 – 2.010
|
0.214
|
|
education_cat_adjusted17+
|
1.026
|
0.600 – 1.738
|
0.925
|
0.994
|
0.578 – 1.691
|
0.982
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:smoke_bi_adjustedYes
|
0.983
|
0.900 – 1.075
|
0.704
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.101
|
0.959 – 1.256
|
0.161
|
|
exp_avgdeath_10_yr_ST_no2_iqr:smoke_bi_adjustedYes
|
|
|
|
0.835
|
0.685 – 1.013
|
0.071
|
|
Observations
|
837
|
837
|
|
R2 Tjur
|
0.077
|
0.079
|
Modifier = APOE
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
0.037
|
0.000 – 8.507
|
0.237
|
0.042
|
0.003 – 0.483
|
0.014
|
PM 2.5 Exposure from Death(10 year,IQR)
|
0.992
|
0.859 – 1.145
|
0.914
|
|
|
|
APOE adjusted no: +APOE e 4
|
0.124
|
0.019 – 0.782
|
0.028
|
3.451
|
0.737 – 17.962
|
0.126
|
|
Ever Smoker: Yes
|
0.628
|
0.430 – 0.915
|
0.016
|
0.638
|
0.437 – 0.929
|
0.019
|
|
Age at Death(centered)
|
0.998
|
0.967 – 1.030
|
0.888
|
0.998
|
0.967 – 1.030
|
0.922
|
|
Gender: Male
|
1.274
|
0.869 – 1.866
|
0.213
|
1.291
|
0.883 – 1.888
|
0.187
|
|
race_cat_simp_adjustedWhite
|
3.922
|
1.722 – 10.662
|
0.003
|
4.081
|
1.792 – 11.093
|
0.002
|
|
nses z cx adjusted
|
1.224
|
0.934 – 1.602
|
0.141
|
1.255
|
0.961 – 1.640
|
0.096
|
|
splines::bs(death_year_centered)1
|
0.604
|
0.004 – 103.504
|
0.844
|
0.427
|
0.006 – 41.285
|
0.706
|
|
splines::bs(death_year_centered)2
|
1.053
|
0.067 – 16.996
|
0.971
|
0.456
|
0.090 – 2.510
|
0.352
|
|
splines::bs(death_year_centered)3
|
8.321
|
0.175 – 424.249
|
0.286
|
4.494
|
0.396 – 61.494
|
0.241
|
|
Cohort: Expansion
|
1.301
|
0.796 – 2.097
|
0.287
|
1.249
|
0.759 – 2.026
|
0.373
|
|
Cohort: Replacement
|
0.981
|
0.534 – 1.774
|
0.950
|
0.949
|
0.514 – 1.724
|
0.864
|
|
education_cat_adjusted13-16
|
1.294
|
0.848 – 1.990
|
0.235
|
1.294
|
0.848 – 1.986
|
0.234
|
|
education_cat_adjusted17+
|
1.007
|
0.588 – 1.709
|
0.978
|
1.009
|
0.588 – 1.714
|
0.973
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:APOE_adjusted_no+ APOE e4
|
1.145
|
1.043 – 1.261
|
0.005
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.042
|
0.921 – 1.171
|
0.501
|
|
exp_avgdeath_10_yr_ST_no2_iqr:APOE_adjusted_no+ APOE e4
|
|
|
|
0.906
|
0.723 – 1.112
|
0.364
|
|
Observations
|
837
|
837
|
|
R2 Tjur
|
0.082
|
0.078
|
Outcome = LATE stage
Modifier = Sex
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
1.209
|
0.014 – 102.343
|
0.933
|
0.296
|
0.038 – 2.197
|
0.238
|
PM 2.5 Exposure from Death(10 year,IQR)
|
0.976
|
0.865 – 1.099
|
0.685
|
|
|
|
|
Gender: Male
|
1.827
|
0.411 – 8.262
|
0.430
|
0.981
|
0.286 – 3.354
|
0.976
|
|
Age at Death(centered)
|
1.089
|
1.061 – 1.118
|
<0.001
|
1.088
|
1.060 – 1.117
|
<0.001
|
|
race_cat_simp_adjustedWhite
|
1.221
|
0.720 – 2.094
|
0.462
|
1.263
|
0.742 – 2.178
|
0.393
|
|
nses z cx adjusted
|
0.927
|
0.743 – 1.156
|
0.501
|
0.886
|
0.712 – 1.101
|
0.275
|
|
splines::bs(death_year_centered)1
|
0.674
|
0.011 – 41.595
|
0.850
|
1.124
|
0.029 – 46.939
|
0.951
|
|
splines::bs(death_year_centered)2
|
0.591
|
0.068 – 5.135
|
0.633
|
1.033
|
0.274 – 3.972
|
0.962
|
|
splines::bs(death_year_centered)3
|
0.937
|
0.037 – 23.558
|
0.968
|
2.215
|
0.266 – 19.395
|
0.466
|
APOE adjusted no: +APOE e 4
|
1.635
|
1.173 – 2.283
|
0.004
|
1.628
|
1.168 – 2.272
|
0.004
|
|
Cohort: Expansion
|
0.931
|
0.620 – 1.394
|
0.727
|
0.893
|
0.591 – 1.343
|
0.587
|
|
Cohort: Replacement
|
0.774
|
0.462 – 1.291
|
0.328
|
0.755
|
0.450 – 1.260
|
0.284
|
|
education_cat_adjusted13-16
|
1.172
|
0.837 – 1.642
|
0.356
|
1.161
|
0.828 – 1.628
|
0.388
|
|
education_cat_adjusted17+
|
1.105
|
0.718 – 1.700
|
0.649
|
1.093
|
0.710 – 1.684
|
0.686
|
|
Ever Smoker: Yes
|
0.993
|
0.732 – 1.348
|
0.962
|
0.978
|
0.721 – 1.327
|
0.884
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:male_catMale
|
0.976
|
0.905 – 1.052
|
0.532
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.045
|
0.936 – 1.167
|
0.434
|
|
exp_avgdeath_10_yr_ST_no2_iqr:male_catMale
|
|
|
|
1.021
|
0.868 – 1.202
|
0.799
|
|
Observations
|
816
|
816
|
|
R2 Tjur
|
0.080
|
0.081
|
Modifier = Smoking
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
1.313
|
0.015 – 116.925
|
0.905
|
0.194
|
0.023 – 1.537
|
0.124
|
PM 2.5 Exposure from Death(10 year,IQR)
|
0.971
|
0.858 – 1.097
|
0.636
|
|
|
|
|
Ever Smoker: Yes
|
1.216
|
0.276 – 5.349
|
0.796
|
1.883
|
0.556 – 6.487
|
0.312
|
|
Age at Death(centered)
|
1.088
|
1.060 – 1.118
|
<0.001
|
1.086
|
1.058 – 1.116
|
<0.001
|
|
Gender: Male
|
1.148
|
0.843 – 1.565
|
0.381
|
1.149
|
0.844 – 1.565
|
0.378
|
|
race_cat_simp_adjustedWhite
|
1.235
|
0.730 – 2.115
|
0.435
|
1.246
|
0.734 – 2.141
|
0.419
|
|
nses z cx adjusted
|
0.926
|
0.742 – 1.154
|
0.493
|
0.884
|
0.710 – 1.098
|
0.266
|
|
splines::bs(death_year_centered)1
|
0.687
|
0.012 – 42.370
|
0.857
|
1.089
|
0.028 – 45.710
|
0.964
|
|
splines::bs(death_year_centered)2
|
0.588
|
0.067 – 5.097
|
0.630
|
1.017
|
0.270 – 3.915
|
0.980
|
|
splines::bs(death_year_centered)3
|
0.930
|
0.037 – 23.348
|
0.965
|
2.180
|
0.261 – 19.116
|
0.475
|
APOE adjusted no: +APOE e 4
|
1.629
|
1.169 – 2.273
|
0.004
|
1.648
|
1.181 – 2.302
|
0.003
|
|
Cohort: Expansion
|
0.926
|
0.617 – 1.386
|
0.708
|
0.887
|
0.588 – 1.336
|
0.568
|
|
Cohort: Replacement
|
0.775
|
0.463 – 1.293
|
0.331
|
0.756
|
0.450 – 1.262
|
0.286
|
|
education_cat_adjusted13-16
|
1.180
|
0.843 – 1.653
|
0.336
|
1.168
|
0.833 – 1.639
|
0.369
|
|
education_cat_adjusted17+
|
1.117
|
0.726 – 1.717
|
0.614
|
1.086
|
0.704 – 1.673
|
0.709
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:smoke_bi_adjustedYes
|
0.989
|
0.917 – 1.067
|
0.776
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.111
|
0.978 – 1.268
|
0.112
|
|
exp_avgdeath_10_yr_ST_no2_iqr:smoke_bi_adjustedYes
|
|
|
|
0.914
|
0.775 – 1.074
|
0.279
|
|
Observations
|
816
|
816
|
|
R2 Tjur
|
0.080
|
0.083
|
Modifier = APOE
|
Â
|
PM 2.5
|
NO2
|
|
Predictors
|
Odds Ratios
|
CI
|
p
|
Odds Ratios
|
CI
|
p
|
|
(Intercept)
|
1.151
|
0.014 – 94.135
|
0.950
|
0.159
|
0.020 – 1.202
|
0.078
|
PM 2.5 Exposure from Death(10 year,IQR)
|
0.976
|
0.869 – 1.095
|
0.675
|
|
|
|
APOE adjusted no: +APOE e 4
|
4.063
|
0.760 – 22.831
|
0.105
|
7.152
|
1.877 – 28.794
|
0.005
|
|
Ever Smoker: Yes
|
0.985
|
0.727 – 1.337
|
0.922
|
1.000
|
0.736 – 1.360
|
0.999
|
|
Age at Death(centered)
|
1.089
|
1.061 – 1.119
|
<0.001
|
1.088
|
1.060 – 1.117
|
<0.001
|
|
Gender: Male
|
1.151
|
0.846 – 1.569
|
0.371
|
1.142
|
0.838 – 1.556
|
0.401
|
|
race_cat_simp_adjustedWhite
|
1.253
|
0.739 – 2.149
|
0.407
|
1.287
|
0.758 – 2.212
|
0.354
|
|
nses z cx adjusted
|
0.930
|
0.745 – 1.159
|
0.516
|
0.890
|
0.715 – 1.106
|
0.293
|
|
splines::bs(death_year_centered)1
|
0.747
|
0.013 – 45.898
|
0.889
|
1.414
|
0.036 – 59.980
|
0.854
|
|
splines::bs(death_year_centered)2
|
0.575
|
0.066 – 4.972
|
0.615
|
1.003
|
0.265 – 3.875
|
0.996
|
|
splines::bs(death_year_centered)3
|
0.962
|
0.039 – 24.115
|
0.981
|
2.583
|
0.308 – 22.829
|
0.386
|
|
Cohort: Expansion
|
0.921
|
0.613 – 1.379
|
0.689
|
0.902
|
0.597 – 1.359
|
0.621
|
|
Cohort: Replacement
|
0.776
|
0.463 – 1.295
|
0.333
|
0.741
|
0.440 – 1.241
|
0.256
|
|
education_cat_adjusted13-16
|
1.179
|
0.843 – 1.652
|
0.337
|
1.178
|
0.840 – 1.654
|
0.344
|
|
education_cat_adjusted17+
|
1.118
|
0.727 – 1.719
|
0.612
|
1.084
|
0.703 – 1.671
|
0.715
|
|
exp_avgdeath_10_yr_ST_pm25_iqr:APOE_adjusted_no+ APOE e4
|
0.954
|
0.875 – 1.038
|
0.282
|
|
|
|
NO 2 Exposure from Death(10 year,IQR)
|
|
|
|
1.118
|
1.011 – 1.239
|
0.031
|
|
exp_avgdeath_10_yr_ST_no2_iqr:APOE_adjusted_no+ APOE e4
|
|
|
|
0.818
|
0.680 – 0.975
|
0.028
|
|
Observations
|
816
|
816
|
|
R2 Tjur
|
0.081
|
0.085
|
Summarizing All Results
Tables to Summarize Aim 1
Model 2
|
|
Overall
|
< 90
|
90+
|
|
Outcome
|
pm25 Effect Estimate
|
95% CI
|
pm25 Effect Estimate
|
95% CI
|
pm25 Effect Estimate
|
95% CI
|
|
HS
|
1.012
|
0.862, 1.189
|
1.066
|
0.839, 1.354
|
0.975
|
0.776, 1.225
|
|
LBD
|
1.033
|
0.898, 1.188
|
1.056
|
0.869, 1.283
|
0.960
|
0.78, 1.182
|
|
LATE
|
0.965
|
0.861, 1.082
|
0.969
|
0.822, 1.142
|
0.954
|
0.81, 1.123
|
Model 3
|
|
Overall
|
< 90
|
90+
|
|
Outcome
|
pm25 Effect Estimate
|
95% CI
|
pm25 Effect Estimate
|
95% CI
|
pm25 Effect Estimate
|
95% CI
|
|
HS
|
1.014
|
0.86, 1.194
|
1.087
|
0.849, 1.392
|
0.953
|
0.758, 1.198
|
|
LBD
|
1.023
|
0.888, 1.18
|
1.015
|
0.827, 1.245
|
0.947
|
0.766, 1.172
|
|
LATE
|
0.942
|
0.838, 1.06
|
0.908
|
0.764, 1.079
|
0.973
|
0.822, 1.151
|
Model 2
|
|
Overall
|
< 90
|
90+
|
|
Outcome
|
NO2 Effect Estimate
|
95% CI
|
NO2 Effect Estimate
|
95% CI
|
NO2 Effect Estimate
|
95% CI
|
|
HS
|
1.048
|
0.934, 1.176
|
1.018
|
0.841, 1.231
|
1.065
|
0.916, 1.239
|
|
LBD
|
1.012
|
0.913, 1.121
|
1.021
|
0.875, 1.191
|
1.027
|
0.888, 1.188
|
|
LATE
|
1.054
|
0.967, 1.149
|
1.063
|
0.933, 1.211
|
1.021
|
0.908, 1.148
|
Model 3
|
|
Overall
|
< 90
|
90+
|
|
Outcome
|
NO2 Effect Estimate
|
95% CI
|
NO2 Effect Estimate
|
95% CI
|
NO2 Effect Estimate
|
95% CI
|
|
HS
|
1.050
|
0.934, 1.179
|
1.032
|
0.854, 1.247
|
1.091
|
0.934, 1.275
|
|
LBD
|
1.005
|
0.905, 1.117
|
1.006
|
0.852, 1.188
|
1.015
|
0.875, 1.177
|
|
LATE
|
1.038
|
0.95, 1.134
|
1.029
|
0.897, 1.18
|
0.998
|
0.885, 1.127
|
Tables to Summarize Aim 2
PM2.5
|
|
Modifier = No
|
Modifier = Yes
|
|
|
Modifier
|
PM2.5 Effect Estimate
|
95% CI
|
PM2.5 Effect Estimate
|
95% CI
|
Ratio
|
95% CI
|
|
HS
|
|
Sex
|
0.998
|
0.842, 1.183
|
0.987
|
0.744, 1.309
|
1.028
|
0.933, 1.133
|
|
Smoking
|
1.000
|
0.841, 1.189
|
0.998
|
0.752, 1.325
|
1.022
|
0.926, 1.128
|
|
APOE
|
1.029
|
0.874, 1.212
|
1.023
|
0.791, 1.323
|
0.944
|
0.847, 1.052
|
|
LBD
|
|
Sex
|
1.007
|
0.869, 1.166
|
1.069
|
0.87, 1.312
|
1.051
|
0.961, 1.148
|
|
Smoking
|
1.046
|
0.902, 1.213
|
1.060
|
0.865, 1.3
|
0.983
|
0.9, 1.074
|
|
APOE
|
0.992
|
0.86, 1.145
|
1.186
|
0.964, 1.46
|
1.145
|
1.042, 1.259
|
|
LATE
|
|
Sex
|
0.976
|
0.866, 1.099
|
0.879
|
0.727, 1.062
|
0.976
|
0.905, 1.053
|
|
Smoking
|
0.971
|
0.859, 1.098
|
0.920
|
0.768, 1.103
|
0.989
|
0.917, 1.066
|
|
APOE
|
0.976
|
0.869, 1.095
|
0.919
|
0.766, 1.102
|
0.954
|
0.876, 1.039
|
NO2
|
|
Modifier = No
|
Modifier = Yes
|
|
|
Modifier
|
PM2.5 Effect Estimate
|
95% CI
|
PM2.5 Effect Estimate
|
95% CI
|
Ratio
|
95% CI
|
|
HS
|
|
Sex
|
1.024
|
0.88, 1.191
|
1.130
|
0.888, 1.438
|
1.054
|
0.851, 1.304
|
|
Smoking
|
1.005
|
0.85, 1.188
|
1.184
|
0.947, 1.479
|
1.079
|
0.871, 1.337
|
|
APOE
|
1.005
|
0.85, 1.188
|
1.219
|
0.953, 1.559
|
1.079
|
0.871, 1.337
|
|
LBD
|
|
Sex
|
0.979
|
0.856, 1.12
|
1.071
|
0.873, 1.313
|
1.077
|
0.89, 1.302
|
|
Smoking
|
1.101
|
0.963, 1.258
|
0.952
|
0.769, 1.178
|
0.835
|
0.687, 1.015
|
|
APOE
|
1.042
|
0.924, 1.174
|
0.989
|
0.785, 1.246
|
0.906
|
0.732, 1.121
|
|
LATE
|
|
Sex
|
1.045
|
0.936, 1.166
|
0.956
|
0.788, 1.161
|
1.021
|
0.869, 1.201
|
|
Smoking
|
1.111
|
0.976, 1.264
|
0.957
|
0.81, 1.131
|
0.914
|
0.777, 1.076
|
|
APOE
|
1.118
|
1.01, 1.237
|
0.840
|
0.666, 1.059
|
0.818
|
0.684, 0.978
|
Bootstrapped Results
Aims 1 and 2
Unstratified Results: PM2.5
|
Model
|
PM2.5 Effect Estimate
|
CI
|
|
LBD
|
|
Model 1
|
0.907
|
0.853, 0.965
|
|
Model 2
|
1.032
|
0.9, 1.227
|
|
Model 3
|
1.023
|
0.892, 1.22
|
Unstratified Results: NO2
|
Model
|
NO2 Effect Estimate
|
CI
|
|
LBD
|
|
Model 1
|
0.931
|
0.837, 1.019
|
|
Model 2
|
1.012
|
0.922, 1.115
|
|
Model 3
|
1.005
|
0.917, 1.116
|
Results stratified by age group
PM2.5
|
|
< 90
|
90+
|
|
Exposure
|
AP Effect Estimate
|
CI
|
AP Effect Estimate
|
CI
|
|
PM2.5
|
1.055
|
0.782, 1.232
|
0.960
|
0.875, 1.363
|
|
NO2
|
1.021
|
0.882, 1.183
|
1.028
|
0.905, 1.185
|
For all participants
|
|
Modifier = No
|
Modifier = Yes
|
|
|
Model
|
PM2.5 Effect Estimate
|
CI
|
PM2.5 Effect Estimate
|
CI
|
Ratio
|
CI
|
|
Outcome = LBD
|
|
Male
|
1.006
|
0.868, 1.199
|
1.057
|
0.915, 1.262
|
1.051
|
0.959, 1.153
|
|
Ever smoker
|
1.045
|
0.903, 1.265
|
1.028
|
0.89, 1.226
|
0.983
|
0.884, 1.083
|
|
APOE e4+
|
0.992
|
0.865, 1.189
|
1.136
|
0.97, 1.351
|
1.146
|
1.042, 1.3
|
NO2
|
|
Modifier = No
|
Modifier = Yes
|
|
|
Model
|
NO2 Effect Estimate
|
CI
|
NO2 Effect Estimate
|
CI
|
Ratio
|
CI
|
|
Outcome = LBD
|
|
Male
|
0.979
|
0.851, 1.084
|
1.054
|
0.931, 1.233
|
1.077
|
0.916, 1.311
|
|
Ever smoker
|
1.101
|
0.979, 1.269
|
0.920
|
0.789, 1.042
|
0.836
|
0.685, 0.983
|
|
APOE e4+
|
1.042
|
0.929, 1.175
|
0.944
|
0.825, 1.121
|
0.906
|
0.762, 1.099
|
## Warning: Using `size` aesthetic for lines was deprecated in ggplot2 3.4.0.
## ℹ Please use `linewidth` instead.
## This warning is displayed once every 8 hours.
## Call `lifecycle::last_lifecycle_warnings()` to see where this warning was
## generated.


Tables for Debby on 09/06/24
|
LBP- and clinical diagnosis (N=275) |
LBP- and no clinical diagnosis (N=382) |
LBP+ and clinical diagnosis (N=106) |
LBP+ and no clinical diagnosis (N=74) |
Overall (N=837) |
| CERAD_cat_ordered |
|
|
|
|
|
| None |
38 (13.8%) |
125 (32.7%) |
8 (7.5%) |
15 (20.3%) |
186 (22.2%) |
| Sparse |
50 (18.2%) |
108 (28.3%) |
17 (16.0%) |
27 (36.5%) |
202 (24.1%) |
| Moderate |
74 (26.9%) |
80 (20.9%) |
24 (22.6%) |
17 (23.0%) |
195 (23.3%) |
| Frequent |
112 (40.7%) |
61 (16.0%) |
50 (47.2%) |
12 (16.2%) |
235 (28.1%) |
| Missing |
1 (0.4%) |
8 (2.1%) |
7 (6.6%) |
3 (4.1%) |
19 (2.3%) |
| Braak_cat_ordered |
|
|
|
|
|
| 0 |
5 (1.8%) |
17 (4.5%) |
1 (0.9%) |
1 (1.4%) |
24 (2.9%) |
| B1 |
33 (12.0%) |
145 (38.0%) |
6 (5.7%) |
17 (23.0%) |
201 (24.0%) |
| B2 |
75 (27.3%) |
146 (38.2%) |
28 (26.4%) |
38 (51.4%) |
287 (34.3%) |
| B3 |
161 (58.5%) |
62 (16.2%) |
63 (59.4%) |
14 (18.9%) |
300 (35.8%) |
| Missing |
1 (0.4%) |
12 (3.1%) |
8 (7.5%) |
4 (5.4%) |
25 (3.0%) |
| as.factor(lewybodydis_cat) |
|
|
|
|
|
| 1 |
275 (100%) |
381 (99.7%) |
0 (0%) |
0 (0%) |
656 (78.4%) |
| 1.5 |
0 (0%) |
1 (0.3%) |
0 (0%) |
0 (0%) |
1 (0.1%) |
| 2 |
0 (0%) |
0 (0%) |
28 (26.4%) |
11 (14.9%) |
39 (4.7%) |
| 3 |
0 (0%) |
0 (0%) |
13 (12.3%) |
15 (20.3%) |
28 (3.3%) |
| 4 |
0 (0%) |
0 (0%) |
19 (17.9%) |
19 (25.7%) |
38 (4.5%) |
| 5 |
0 (0%) |
0 (0%) |
1 (0.9%) |
4 (5.4%) |
5 (0.6%) |
| 6 |
0 (0%) |
0 (0%) |
45 (42.5%) |
25 (33.8%) |
70 (8.4%) |
| Thal Phase |
|
|
|
|
|
| 0 |
9 (3.3%) |
28 (7.3%) |
4 (3.8%) |
9 (12.2%) |
50 (6.0%) |
| 1 |
7 (2.5%) |
19 (5.0%) |
4 (3.8%) |
4 (5.4%) |
34 (4.1%) |
| 2 |
14 (5.1%) |
14 (3.7%) |
2 (1.9%) |
7 (9.5%) |
37 (4.4%) |
| 3 |
30 (10.9%) |
38 (9.9%) |
12 (11.3%) |
6 (8.1%) |
86 (10.3%) |
| 4 |
37 (13.5%) |
37 (9.7%) |
23 (21.7%) |
10 (13.5%) |
107 (12.8%) |
| 5 |
27 (9.8%) |
9 (2.4%) |
23 (21.7%) |
6 (8.1%) |
65 (7.8%) |
| Missing |
151 (54.9%) |
237 (62.0%) |
38 (35.8%) |
32 (43.2%) |
458 (54.7%) |
|
LBP- and clinical diagnosis (N=275) |
LBP- and no clinical diagnosis (N=382) |
LBP+ and clinical diagnosis (N=106) |
LBP+ and no clinical diagnosis (N=74) |
Overall (N=837) |
| CERAD_bi |
|
|
|
|
|
| CERAD- |
89 (32.4%) |
241 (63.1%) |
32 (30.2%) |
45 (60.8%) |
407 (48.6%) |
| CERAD+ |
186 (67.6%) |
141 (36.9%) |
74 (69.8%) |
29 (39.2%) |
430 (51.4%) |
| NFT_bi |
|
|
|
|
|
| NFT - |
68 (24.7%) |
250 (65.4%) |
21 (19.8%) |
36 (48.6%) |
375 (44.8%) |
| NFT + |
207 (75.3%) |
132 (34.6%) |
85 (80.2%) |
38 (51.4%) |
462 (55.2%) |
| CERAD_and_NFT |
|
|
|
|
|
| CERAD and NFT - |
107 (38.9%) |
304 (79.6%) |
41 (38.7%) |
59 (79.7%) |
511 (61.1%) |
| CERAD and NFT + |
168 (61.1%) |
78 (20.4%) |
65 (61.3%) |
15 (20.3%) |
326 (38.9%) |
| Age at Death |
|
|
|
|
|
| Mean (SD) |
91.1 (5.84) |
87.5 (6.97) |
90.2 (5.58) |
88.8 (7.09) |
89.2 (6.65) |
| Median [Min, Max] |
91.2 [73.7, 106] |
88.1 [68.9, 102] |
91.0 [76.7, 99.8] |
88.7 [74.6, 102] |
89.7 [68.9, 106] |
| Gender |
|
|
|
|
|
| Female |
165 (60.0%) |
213 (55.8%) |
64 (60.4%) |
39 (52.7%) |
481 (57.5%) |
| Male |
110 (40.0%) |
169 (44.2%) |
42 (39.6%) |
35 (47.3%) |
356 (42.5%) |
| as.factor(lewybodydis_cat) |
|
|
|
|
|
| 1 |
275 (100%) |
381 (99.7%) |
0 (0%) |
0 (0%) |
656 (78.4%) |
| 1.5 |
0 (0%) |
1 (0.3%) |
0 (0%) |
0 (0%) |
1 (0.1%) |
| 2 |
0 (0%) |
0 (0%) |
28 (26.4%) |
11 (14.9%) |
39 (4.7%) |
| 3 |
0 (0%) |
0 (0%) |
13 (12.3%) |
15 (20.3%) |
28 (3.3%) |
| 4 |
0 (0%) |
0 (0%) |
19 (17.9%) |
19 (25.7%) |
38 (4.5%) |
| 5 |
0 (0%) |
0 (0%) |
1 (0.9%) |
4 (5.4%) |
5 (0.6%) |
| 6 |
0 (0%) |
0 (0%) |
45 (42.5%) |
25 (33.8%) |
70 (8.4%) |
cross tab for LBP- and clinical diagnosis + group
##
## NFT - NFT +
## CERAD- 50 39
## CERAD+ 18 168
##
## Pearson's Chi-squared test with Yates' continuity correction
##
## data: t1
## X-squared = 67.461, df = 1, p-value < 2.2e-16
cross tab for LBP- and clinical diagnosis - group
##
## NFT - NFT +
## CERAD- 187 54
## CERAD+ 63 78
##
## Pearson's Chi-squared test with Yates' continuity correction
##
## data: t2
## X-squared = 41.167, df = 1, p-value = 1.398e-10
cross tab for LBP+ and clinical diagnosis + group
##
## NFT - NFT +
## CERAD- 12 20
## CERAD+ 9 65
##
## Pearson's Chi-squared test with Yates' continuity correction
##
## data: t3
## X-squared = 7.5034, df = 1, p-value = 0.006158
cross tab for LBP+ and clinical diagnosis - group
##
## NFT - NFT +
## CERAD- 22 23
## CERAD+ 14 15
##
## Pearson's Chi-squared test with Yates' continuity correction
##
## data: t4
## X-squared = 0, df = 1, p-value = 1
|
AD NP - and clinical diagnosis (N=148) |
AD NP - and no clinical diagnosis (N=363) |
AD NP + and clinical diagnosis (N=233) |
AD NP + and no clinical diagnosis (N=93) |
Overall (N=837) |
| as.factor(lewybodydis_cat) |
|
|
|
|
|
| 1 |
107 (72.3%) |
303 (83.5%) |
168 (72.1%) |
78 (83.9%) |
656 (78.4%) |
| 1.5 |
0 (0%) |
1 (0.3%) |
0 (0%) |
0 (0%) |
1 (0.1%) |
| 2 |
3 (2.0%) |
6 (1.7%) |
25 (10.7%) |
5 (5.4%) |
39 (4.7%) |
| 3 |
10 (6.8%) |
14 (3.9%) |
3 (1.3%) |
1 (1.1%) |
28 (3.3%) |
| 4 |
8 (5.4%) |
17 (4.7%) |
11 (4.7%) |
2 (2.2%) |
38 (4.5%) |
| 5 |
0 (0%) |
4 (1.1%) |
1 (0.4%) |
0 (0%) |
5 (0.6%) |
| 6 |
20 (13.5%) |
18 (5.0%) |
25 (10.7%) |
7 (7.5%) |
70 (8.4%) |
| CERAD_cat_ordered |
|
|
|
|
|
| None |
46 (31.1%) |
140 (38.6%) |
0 (0%) |
0 (0%) |
186 (22.2%) |
| Sparse |
67 (45.3%) |
135 (37.2%) |
0 (0%) |
0 (0%) |
202 (24.1%) |
| Moderate |
17 (11.5%) |
54 (14.9%) |
81 (34.8%) |
43 (46.2%) |
195 (23.3%) |
| Frequent |
10 (6.8%) |
23 (6.3%) |
152 (65.2%) |
50 (53.8%) |
235 (28.1%) |
| Missing |
8 (5.4%) |
11 (3.0%) |
0 (0%) |
0 (0%) |
19 (2.3%) |
| Braak_cat_ordered |
|
|
|
|
|
| 0 |
6 (4.1%) |
18 (5.0%) |
0 (0%) |
0 (0%) |
24 (2.9%) |
| B1 |
39 (26.4%) |
162 (44.6%) |
0 (0%) |
0 (0%) |
201 (24.0%) |
| B2 |
72 (48.6%) |
154 (42.4%) |
31 (13.3%) |
30 (32.3%) |
287 (34.3%) |
| B3 |
22 (14.9%) |
15 (4.1%) |
202 (86.7%) |
61 (65.6%) |
300 (35.8%) |
| Missing |
9 (6.1%) |
14 (3.9%) |
0 (0%) |
2 (2.2%) |
25 (3.0%) |
New table on 12/05/2024
|
Lewy body category
|
No dementia (n)
|
Dementia (n)
|
|
2
|
11
|
28
|
|
3
|
15
|
13
|
|
4
|
19
|
19
|
|
5
|
4
|
1
|
|
6
|
25
|
45
|
|
LBP- and clinical diagnosis (N=275) |
LBP- and no clinical diagnosis (N=382) |
LBP+ and clinical diagnosis (N=106) |
LBP+ and no clinical diagnosis (N=74) |
Overall (N=837) |
| CERAD_cat_ordered |
|
|
|
|
|
| None |
38 (13.8%) |
125 (32.7%) |
8 (7.5%) |
15 (20.3%) |
186 (22.2%) |
| Sparse |
50 (18.2%) |
108 (28.3%) |
17 (16.0%) |
27 (36.5%) |
202 (24.1%) |
| Moderate |
74 (26.9%) |
80 (20.9%) |
24 (22.6%) |
17 (23.0%) |
195 (23.3%) |
| Frequent |
112 (40.7%) |
61 (16.0%) |
50 (47.2%) |
12 (16.2%) |
235 (28.1%) |
| Missing |
1 (0.4%) |
8 (2.1%) |
7 (6.6%) |
3 (4.1%) |
19 (2.3%) |
| Braak_cat_ordered |
|
|
|
|
|
| 0 |
5 (1.8%) |
17 (4.5%) |
1 (0.9%) |
1 (1.4%) |
24 (2.9%) |
| B1 |
33 (12.0%) |
145 (38.0%) |
6 (5.7%) |
17 (23.0%) |
201 (24.0%) |
| B2 |
75 (27.3%) |
146 (38.2%) |
28 (26.4%) |
38 (51.4%) |
287 (34.3%) |
| B3 |
161 (58.5%) |
62 (16.2%) |
63 (59.4%) |
14 (18.9%) |
300 (35.8%) |
| Missing |
1 (0.4%) |
12 (3.1%) |
8 (7.5%) |
4 (5.4%) |
25 (3.0%) |
| as.factor(lewybodydis_cat) |
|
|
|
|
|
| 1 |
275 (100%) |
381 (99.7%) |
0 (0%) |
0 (0%) |
656 (78.4%) |
| 1.5 |
0 (0%) |
1 (0.3%) |
0 (0%) |
0 (0%) |
1 (0.1%) |
| 2 |
0 (0%) |
0 (0%) |
28 (26.4%) |
11 (14.9%) |
39 (4.7%) |
| 3 |
0 (0%) |
0 (0%) |
13 (12.3%) |
15 (20.3%) |
28 (3.3%) |
| 4 |
0 (0%) |
0 (0%) |
19 (17.9%) |
19 (25.7%) |
38 (4.5%) |
| 5 |
0 (0%) |
0 (0%) |
1 (0.9%) |
4 (5.4%) |
5 (0.6%) |
| 6 |
0 (0%) |
0 (0%) |
45 (42.5%) |
25 (33.8%) |
70 (8.4%) |
| Thal Phase |
|
|
|
|
|
| 0 |
9 (3.3%) |
28 (7.3%) |
4 (3.8%) |
9 (12.2%) |
50 (6.0%) |
| 1 |
7 (2.5%) |
19 (5.0%) |
4 (3.8%) |
4 (5.4%) |
34 (4.1%) |
| 2 |
14 (5.1%) |
14 (3.7%) |
2 (1.9%) |
7 (9.5%) |
37 (4.4%) |
| 3 |
30 (10.9%) |
38 (9.9%) |
12 (11.3%) |
6 (8.1%) |
86 (10.3%) |
| 4 |
37 (13.5%) |
37 (9.7%) |
23 (21.7%) |
10 (13.5%) |
107 (12.8%) |
| 5 |
27 (9.8%) |
9 (2.4%) |
23 (21.7%) |
6 (8.1%) |
65 (7.8%) |
| Missing |
151 (54.9%) |
237 (62.0%) |
38 (35.8%) |
32 (43.2%) |
458 (54.7%) |